U S ENERGY CORP - DELAWARE (USEG)

US9118053076 - Common Stock

1.19  -0.02 (-1.65%)

Fundamental Rating

2

Taking everything into account, USEG scores 2 out of 10 in our fundamental rating. USEG was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. USEG may be in some trouble as it scores bad on both profitability and health. USEG has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year USEG has reported negative net income.
In the past year USEG had a positive cash flow from operations.
USEG had negative earnings in each of the past 5 years.
In multiple years USEG reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -13.28%, USEG is doing worse than 93.90% of the companies in the same industry.
USEG has a worse Return On Equity (-21.71%) than 88.26% of its industry peers.
Industry RankSector Rank
ROA -13.28%
ROE -21.71%
ROIC N/A
ROA(3y)-20.86%
ROA(5y)-15.73%
ROE(3y)-29.69%
ROE(5y)-21.8%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

USEG has a Gross Margin of 14.99%. This is in the lower half of the industry: USEG underperforms 71.36% of its industry peers.
USEG's Gross Margin has declined in the last couple of years.
USEG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.55%
GM growth 5Y-1.99%

3

2. Health

2.1 Basic Checks

USEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for USEG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

USEG has an Altman-Z score of -1.47. This is a bad value and indicates that USEG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of USEG (-1.47) is worse than 73.71% of its industry peers.
The Debt to FCF ratio of USEG is 0.87, which is an excellent value as it means it would take USEG, only 0.87 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.87, USEG belongs to the top of the industry, outperforming 84.98% of the companies in the same industry.
USEG has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
USEG has a better Debt to Equity ratio (0.18) than 70.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.87
Altman-Z -1.47
ROIC/WACCN/A
WACC8.81%

2.3 Liquidity

USEG has a Current Ratio of 0.55. This is a bad value and indicates that USEG is not financially healthy enough and could expect problems in meeting its short term obligations.
USEG has a Current ratio of 0.55. This is amonst the worse of the industry: USEG underperforms 87.32% of its industry peers.
A Quick Ratio of 0.55 indicates that USEG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.55, USEG is doing worse than 83.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55

2

3. Growth

3.1 Past

USEG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.55%.
Looking at the last year, USEG shows a decrease in Revenue. The Revenue has decreased by -2.21% in the last year.
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-96.55%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-318.75%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y89.28%
Revenue growth 5Y46.73%
Revenue growth Q2Q-25.93%

3.2 Future

Based on estimates for the next years, USEG will show a very negative growth in Earnings Per Share. The EPS will decrease by -147.66% on average per year.
The Revenue is expected to decrease by -18.35% on average over the next years. This is quite bad
EPS Next Y-806.67%
EPS Next 2Y-147.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-26.86%
Revenue Next 2Y-18.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

USEG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for USEG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USEG indicates a slightly more expensive valuation: USEG is more expensive than 64.79% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, USEG is valued cheaper than 96.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.2
EV/EBITDA 9.82

4.3 Compensation for Growth

A cheap valuation may be justified as USEG's earnings are expected to decrease with -147.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-147.66%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

USEG has a Yearly Dividend Yield of 1.74%.
USEG's Dividend Yield is comparable with the industry average which is at 5.79.
Compared to the average S&P500 Dividend Yield of 2.45, USEG is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

USEG is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

USEG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-12.32%
EPS Next 2Y-147.66%
EPS Next 3YN/A

U S ENERGY CORP - DELAWARE

NASDAQ:USEG (4/25/2024, 10:53:26 AM)

1.19

-0.02 (-1.65%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap30.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.28%
ROE -21.71%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 14.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-96.55%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-806.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y89.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y